Last Updated on December 24, 2023 by The Health Master
ANDA Approval
Glenmark Pharmaceuticals, a leading pharmaceutical company, has successfully secured final ANDA Approval for its Tacrolimus Ointment, 0.03% from U.S. Food and Drug Administration (USFDA).
This newly approved medication stands as the generic equivalent of Leo Pharma AS’s Protopic Ointment, 0.03%, marking a significant stride in the pharmaceutical industry.
Glenmark’s Venture into the US Market:
Glenmark’s accomplishment is complemented by its upcoming plans for the distribution of Tacrolimus Ointment, 0.03%, across the United States through its subsidiary, Glenmark Pharmaceuticals US.
This move is expected to solidify Glenmark’s presence in the US pharmaceutical landscape.
Glenmark’s ANDA approval:
Glenmark Pharmaceuticals boasts a diverse portfolio, encompassing a total of 184 products that have received authorization for distribution within the expansive US marketplace.
Additionally, the company has 51 awaiting ANDA approval from the US FDA, further reflecting Glenmark’s commitment to innovation and meeting evolving healthcare demands.
Key Takeaways:
In summary, Glenmark Pharmaceuticals’ attainment of USFDA ANDA approval for its Tacrolimus Ointment, 0.03%, signifies a pivotal achievement in the generic pharmaceutical sector.
The company’s strategic approach to entering the US market through its subsidiary underscores its dedication to enhancing accessibility to crucial medications.
Furthermore, IQVIA’s data showcasing the substantial sales of Protopic Ointment, 0.03%, reinforces the market’s demand for effective treatment options.
With a wide-ranging portfolio and pending ANDA approvals, Glenmark Pharmaceuticals remains poised to contribute significantly to the healthcare landscape by catering to diverse medical requirements.
Disclaimer: This article contains information derived from the source mentioned below. Our team utilized an AI language model, to rewrite and present the news / article in a unique format.
USFDA gives nod for this cancer treatment generic injection
USFDA gives approval for Icatibant injection
USFDA gives approval for this drug to treat Rare Blood Disease
USFDA gives nod for Potassium Chloride for Injection Concentrate
USFDA gives nod for Bromfenac Ophthalmic Solution, Metoprolol Tablets
USFDA gives approval for Doxycycline Hyclate delayed-release Tablets
USFDA gives nod for this cancer treatment generic injection
Drug recall: Alembic, Aurobindo recall these drugs for this reason
USFDA gives approval for Icatibant injection
National Policy ready for R&D in Pharma-Medical Device Industry
USFDA gives approval for this drug to treat Rare Blood Disease
India launches Rs 5,000 Crore R&D Incentive Scheme for Pharma Industry
Major FDA audit findings about Equipment and Instruments
DCGI issued alert for falsified this diabetes management drugs
Procedural lapses flagged at Aurobindo Pharma by USFDA: Telangana
For informative videos by The Health Master, click on the below YouTube icon:
For informative videos on Medical Store / Pharmacy, click on the below YouTube icon:
For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:
For informative videos on consumer awareness, click on the below YouTube icon:
